Filing Details

Accession Number:
0001104659-20-109014
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-09-25 18:37:08
Reporting Period:
2020-09-22
Accepted Time:
2020-09-25 18:37:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1429260 Fortress Biotech Inc. FBIO Pharmaceutical Preparations (2834) 205157386
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1713932 Robyn Hunter C/o Fortress Biotech, Inc.
2 Gansevoort Street, 9Th Floor
New York NY 10014
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.001 Disposition 2020-09-22 28,450 $4.38 192,169 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. In connection with the vesting of 62,500 shares on September 18, 2020, a total of 28,450 of such shares were sold by the Issuer in order to satisfy the Reporting Person's tax withholding obligations. The Reporting Person had no discretion with respect to such sale, which was conducted automatically in accordance with the Issuer's corporate policies.
  2. Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on September 22, 2020, was $4.36 to $4.41. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a shareholder of the Issuer, full information regarding the number of shares sold at each separate price
  3. Of the 192,169 shares, 62,500 shares are restricted stock units.